These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15114971)

  • 1. 2 drugs team up for protection. Old standby joins relative newcomer to battle heart disease.
    Heart Advis; 2003 Aug; 6(8):3. PubMed ID: 15114971
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy for ischemic heart disease.
    Steimle AE
    N Engl J Med; 2004 May; 350(20):2101-2; author reply 2101-2. PubMed ID: 15141055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
    Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiplatelet drugs in prevention and treatment of coronary heart disease: aspirin is obligatory, quite sufficient, and safe].
    Averkov OV
    Kardiologiia; 2003; 43(6):77-83. PubMed ID: 13677327
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation and atherothrombosis.
    Kapoor JR
    N Engl J Med; 2008 Apr; 358(15):1638; author reply 1638-9. PubMed ID: 18403776
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel for preventing cardiovascular events.
    Stulman J; McGinn T; Korenstein D
    Mt Sinai J Med; 2009 Apr; 76(2):194-7. PubMed ID: 19306382
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopidogrel--a myocardial infarction CURE?
    Bradley C
    Intensive Crit Care Nurs; 2001 Dec; 17(6):364-6. PubMed ID: 11853013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Super aspirin" cuts risks after multiple cardiac events.
    Heart Advis; 2004 Apr; 7(4):2. PubMed ID: 15114978
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond aspirin.
    Harv Heart Lett; 1998 Jun; 8(10):1-3. PubMed ID: 9619133
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent antiplatelet and fibrinolytic therapy.
    Lange RA; Hillis LD
    N Engl J Med; 2005 Mar; 352(12):1248-50. PubMed ID: 15758001
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myocardial infarct, stroke and vascular events reduced by a third].
    Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
    [No Abstract]   [Full Text] [Related]  

  • 16. Selecting the optimal stroke prevention therapy in atrial fibrillation.
    Fang MC
    Ann Intern Med; 2011 Nov; 155(9):636-7. PubMed ID: 22041953
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
    Vyshlov EV; Panfilova EV; Markov VA
    Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment: mortality benefit of no-load clopidogrel in COMMIT: not a surprise.
    Serebruany VL
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):99-100. PubMed ID: 16703225
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.